SERPINA3 and Alzheimer disease: The low content of terminal GlcNac and sialic acid in plasma alpha-1-antichymotrypsin (ACT) (a secondary component of amyloid plaques) in patients with AD appeared to be related to progressive cognitive deterioration [21].